Casdin Capital

Growth Equity

New York, New York, US

Description

Casdin Capital is an investment firm specializing in the life sciences sector, focusing on healthcare, biotechnology, synthetic biology, and technology. The company partners with innovative entities, leveraging data and molecular information to drive investments and foster the development of precision medicine and transformative healthcare solutions.

Recent Transactions involving Casdin Capital

Deal	Target	Platform	Buyer	Industry
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing	GeneMatters	Genome Medical	Casdin Capital GV Illumina Ventures LRVHealth Echo Health Ventures Revelation Partners HealthInvest Equity Partners Avestria Ventures Flywheel Ventures Dreamers Fund Blue Ivy Ventures Amgen Ventures Canaan Partners Kaiser Permanente Ventures Perceptive Advisors	Medical Practices

Deal

Target

Platform

Buyer

Industry

Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing

GeneMatters

Genome Medical

Casdin Capital

GV

Illumina Ventures

LRVHealth

Echo Health Ventures

Revelation Partners

HealthInvest Equity Partners

Avestria Ventures

Flywheel Ventures

Dreamers Fund

Blue Ivy Ventures

Amgen Ventures

Canaan Partners

Kaiser Permanente Ventures

Perceptive Advisors

Medical Practices

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →